Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment

Overview of attention for article published in Blood, June 2011

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)
Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

policy: 1 policy source

patent: 8 patents

Readers on

mendeley: 140 Mendeley
citeulike: 1 CiteULike

So far, Altmetric has seen 8 patents that reference this research output.

PROGNOSTIC GENE SIGNATURE AND METHOD FOR DIFFUSE LARGE B-CELL LYMPHOMA PROGNOSIS AND…

Application US-20230399701-A1

United States of America

14 Dec 2023

HER2/4-1BB BISPECIFIC FUSION PROTEINS FOR THE TREATMENT OF CANCER

Application WO-2022200412-A2

World Intellectual Property Organisation (WIPO)

29 Sep 2022

TUMOR TREATMENT WITH A 4-1BB/HER2-BISPECIFIC AGENT AND A HER2-TARGETED TYROSINE KINASE…

Application WO-2022200478-A1

World Intellectual Property Organisation (WIPO)

29 Sep 2022

HER2/4-1BB BISPECIFIC FUSION PROTEINS FOR THE TREATMENT OF CANCER

Application WO-2021089588-A1

World Intellectual Property Organisation (WIPO)

14 May 2021

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 4 additional patents.